Literature DB >> 2677950

Immunoblot analysis of antibody binding to polypeptides of Borrelia burgdorferi in children with different clinical manifestations of Lyme disease.

D Nadal1, C Taverna, W H Hitzig.   

Abstract

We analyzed by means of immunoblot technique the patterns of antibodies binding to polypeptides of Borrelia burgdorferi B31 in the sera of 21 children with different stages of Lyme disease. All sera but one recognized the flagellar protein 41 kD and all but two the 83-kD protein. The number of proteins recognized rose from clinical stage I to stage III. The polypeptides of the mol wt 55 and 31 kD were exclusively bound by IgM and the proteins 66, 58, 39, and 36 kD exclusively by IgG. Based on the number of proteins visualized by single sera, IgM was the predominant isotype in stages I and II peaking in stage II, whereas in stage III IgG predominated. Considering the number of proteins recognized and the corresponding antibody isotype, a serologic differentiation between the three stages of the disease is feasible: within stage I and within stage III patients with different clinical signs had distinct antibody patterns. No clearcut pattern could be discriminated in stage II for patients with different settings. Immunoblotting yields a possible distinction between active infection and serological scar by the detection of specific antibody patterns.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2677950     DOI: 10.1203/00006450-198910000-00019

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  13 in total

1.  Further characterization of a potent immunogen and the chromosomal gene encoding it in the Lyme disease agent, Borrelia burgdorferi.

Authors:  G C Perng; R B LeFebvre; R C Johnson
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

Review 2.  Lyme disease in paediatrics.

Authors:  B Cryan; D J Wright
Journal:  Arch Dis Child       Date:  1991-11       Impact factor: 3.791

Review 3.  Childhood Lyme borreliosis in Europe.

Authors:  H I Huppertz
Journal:  Eur J Pediatr       Date:  1990-09       Impact factor: 3.183

4.  Immunoblot interpretation criteria for serodiagnosis of early Lyme disease.

Authors:  S M Engstrom; E Shoop; R C Johnson
Journal:  J Clin Microbiol       Date:  1995-02       Impact factor: 5.948

5.  Serodiagnosis in early Lyme disease.

Authors:  M E Aguero-Rosenfeld; J Nowakowski; D F McKenna; C A Carbonaro; G P Wormser
Journal:  J Clin Microbiol       Date:  1993-12       Impact factor: 5.948

6.  Reactivity of human Lyme borreliosis sera with a 39-kilodalton antigen specific to Borrelia burgdorferi.

Authors:  W J Simpson; M E Schrumpf; T G Schwan
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

7.  The 83-kilodalton antigen of Borrelia burgdorferi which stimulates immunoglobulin M (IgM) and IgG responses in infected hosts is expressed by a chromosomal gene.

Authors:  R B Lefebvre; G C Perng; R C Johnson
Journal:  J Clin Microbiol       Date:  1990-07       Impact factor: 5.948

8.  Serodiagnosis of Lyme borreliosis by western immunoblot: reactivity of various significant antibodies against Borrelia burgdorferi.

Authors:  B Ma; B Christen; D Leung; C Vigo-Pelfrey
Journal:  J Clin Microbiol       Date:  1992-02       Impact factor: 5.948

9.  Serologic surveillance for the Lyme disease spirochete, Borrelia burgdorferi, in Minnesota by using white-tailed deer as sentinel animals.

Authors:  J S Gill; R G McLean; R B Shriner; R C Johnson
Journal:  J Clin Microbiol       Date:  1994-02       Impact factor: 5.948

10.  Molecular and immunological analysis of a polymorphic periplasmic protein of Borrelia burgdorferi.

Authors:  W J Simpson; M E Schrumpf; S F Hayes; T G Schwan
Journal:  J Clin Microbiol       Date:  1991-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.